202 results
8-K
EX-99.1
PACB
Pacific Biosciences of California Inc
16 Apr 24
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
8:08am
expense reductions may be greater than anticipated; the availability, uses, accuracy, coverage, advantages, quality or performance of, or benefits … or expected benefits of using, PacBio products or technologies; anticipated demand for PacBio’s products and technologies in future periods. Reported results
8-K
EX-99.1
24d d89c9j2nf5m
15 Feb 24
PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results
4:07pm
8-K
EX-99.1
xcg7l0 re61ei
8 Jan 24
PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively
8:03am
8-K
EX-99.1
ttcgbv7xr5sk68c20v
30 Oct 23
PacBio Announces Third Quarter 2023 Financial Results
4:06pm
8-K
EX-99.2
zmjtthv may47
2 Aug 23
PacBio Announces Second Quarter 2023 Financial Results
4:10pm
8-K
EX-99.1
unj ihjxasn
2 Aug 23
PacBio Announces Second Quarter 2023 Financial Results
4:10pm
8-K
EX-99.3
j1eqfh2im7flv
2 Aug 23
PacBio Announces Second Quarter 2023 Financial Results
4:10pm
8-K
EX-4.1
9p2ph59sxqgzuzd668o
30 Jun 23
Entry into a Material Definitive Agreement
4:25pm
8-K
EX-99.1
4ch26tcbae 60f
23 Jun 23
PacBio Announces a Private Convertible Exchange Transaction of $441 Million Principal Amount of 1.375% Convertible Senior Notes due 2030
7:56pm
SD
EX-1.01
2ldhfxbn
24 May 23
Conflict minerals disclosure
12:00am
8-K
EX-99.1
61kmz q9m0n4
2 May 23
PacBio Announces Record Revenue in First Quarter 2023
4:03pm